Dr. Howard B. Gerber, MD

Dr. Gerber practices at Bellaire Dermatology Associates, P.a. in Bellaire, Texas.

Dr. Gerber's NPI, 1003876285, was assigned on March 23, 2006. Dr. Gerber graduated from McGovern Medical School in 1987. Dr. Gerber holds Texas license H4347.

Dr. Gerber's primary practice is Bellaire Dermatology Associates, P.a., at 6565 W Loop S Suite 800 Suite 800, Bellaire, TX 77401-3500. The practice phone is (713) 661-4383.

Dr. Gerber's primary practice is Bellaire Dermatology Associates, P.a. in Bellaire, Texas. The medical group on file is Bellaire Dermatology. Dmand AI also links Dr. Gerber to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerber practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gerber's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gerber is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gerber's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, itchy rashes and joint cyst among the conditions Dr. Gerber treats.

CMS data shows 15,006 Medicare services from Dr. Gerber across 25 procedure codes in 2024, for 1,829 Medicare patients. Medicare paid $343,503 for them. Every service was in an office.

CMS counts 1,829 Medicare patients who saw Dr. Gerber in 2024. The largest group is 65 to 74, with 836 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gerber's median patient age at 66, with 48% women.

In 2024, Dr. Gerber wrote 631 Medicare Part D claims for 291 patients. 88% of them were for generic drugs. CMS names the drug for 508 of them, across 16 drugs with 11 or more claims each, at $189,370 in total drug cost. In 2023, CMS named 439 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gerber for performance year 2024, reported individually. Dr. Gerber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,295 procedures of removal of skin lesions by Dr. Gerber, more than 95% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Gerber, published from 2014 to 2023. Dr. Gerber has published most often in J Cutan Pathol. Dr. Gerber's most frequent co-authors are Jonathan L. Curry, MD, Madeleine Duvic, MD and Tyler H. Enos, MD.

Dmand AI links Dr. Gerber to 1 clinical trial. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. Gerber that name 1 trial.

CMS Open Payments shows 942 general payments to Dr. Gerber from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $4,444. It also lists 3 research payments totaling $1,423 in 2017, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Gerber.

Dr. Gerber graduated from McGovern Medical School in 1987. Dr. Gerber is a member of AAD.

Dr. Gerber is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.